TCM
RCKT icon

Tekla Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Tekla Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-289,029
Closed -$6.05M – 219
2020
Q2 		$6.05M Buy
289,029
+81,474
+39% +$1.47M 0.23% 90
2020
Q1 		$2.9M Hold
207,555
– – 0.13% 116
2019
Q4 		$4.72M Hold
207,555
– – 0.18% 107
2019
Q3 		$2.42M Buy
+207,555
New +$2.58M 0.11% 128
2016
Q4 		– Sell
-45,191
Closed -$1.71M – 148
2016
Q3 		$1.71M Hold
45,191
– – 0.07% 124
2016
Q2 		$1.34M Sell
45,191
-76,657
-63% -$2.7M 0.06% 143
2016
Q1 		$3.61M Buy
121,848
+15,598
+15% +$468K 0.15% 99
2015
Q4 		$4.82M Hold
106,250
– – 0.17% 96
2015
Q3 		$4M Buy
+106,250
New +$4.88M 0.15% 110

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return